Immunome to Acquire Antibody-Related Assets and Materials from Atreca

Immunome, Inc. , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that it entered into a definitive asset purchase agreement with Atreca, Inc. to acquire a collection of...

Related Keywords

Clayb Siegall , ,Linkedin ,Product Service ,Exchange Commission ,Twitter ,Atreca Inc ,Immunome Inc ,Nasdaq ,Acquire Antibody Related Assets ,Chief Executive Officer ,Exchange Act ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Report ,